@admetsys.com
For people at diabetic risk, glucose control is at its most crucial while in hospital or surgery.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Admetsys is a brand that is revolutionizing the future of critical care through high-precision automation. Their products and services are designed to adapt to each individual patient and automatically implement goals set by clinicians, resulting in repeatable and economical care at scale. One of Admetsys' key offerings is the Admetsys clinical robotics system, which is a cutting-edge blood analysis and metabolic control solution for critical care and surgery.
This system includes the PrecisionOne™ Clinical automation controller, which captures data from biosensors and constructs an evolving computational model of each patient's metabolism in real time. It autonomously regulates patient glucose levels with zero clinician intervention, directly infusing continuously-optimized insulin and dextrose therapy. Additionally, Admetsys provides the Intravenous Laboratory™, a real-time continuous blood diagnostics system that offers automated extracorporeal whole-blood biosensing with zero blood loss to the patient.
This innovative system enables early detection and mitigation of conditions like sepsis and provides up to 7 days of continuous biosensing. By focusing on critical care metabolism, Admetsys aims to control glucose levels effectively, reducing mortality rates and shortening ICU stays. Their high-frequency blood measurements and avoidance of interstitial fluid ensure accuracy in real-time variability monitoring.
This is crucial, as it helps healthcare professionals make timely and informed decisions. By replacing manual processes, Admetsys improves workflow and efficiency, thereby increasing the standard of care. Their PrecisionOne™ clinical performance has been outstanding, with clinical trials reporting 97% control between 80-125 mg/dL, 100% prevention of hypoglycemia, and a mean time to normoglycemia of just 2.
5 hours. Admetsys is headquartered in Boston, MA, USA, and has secured CE Mark approval for commercial use in the EU and EEA. They are committed to transforming critical care through their innovative solutions, and welcome inquiries from interested parties
Company Type
Privately Held
Company Size
2-10
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online